1.	First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy Phase: Phase III, Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA183-002, NCT00389155
2.	Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: L0070 IN 302 P1, CA183004, NCT00315237
3.	Phase II Study of Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium That Relapsed or Progressed After Prior Platinum-Based Chemotherapy Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BMS-CA183001, UPCC-07804, NCT00101608
4.	A Phase II Single Arm Trial of Single-Agent Vinflunine as Second-Line Treatment of Advanced Non-Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: I-05-009, NCT00251446
5.	Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: SCRI LUN 122, CA183017, NCT00284154
6.	Vinflunine Plus Trastuzumab in HER2 Over-Expressing Metastatic Breast Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: SCRI BRE 89, CA183014, NCT00284180
7.	Study of Vinflunine and Cetuximab to Treat Lung Cancer Phase: Phase II Type: Treatment Status: Temporarily closed Age: 18 and over Sponsor: Other Protocol IDs: LCCC 0503, NCT00330031
8.	Phase II Study of Vinflunine and Capecitabine in Patients With Previously Treated Metastatic Breast Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N0632, N0632, NCT00450515
9.	Phase II Study of Vinflunine and Cetuximab as Second-Line Therapy in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UNC-LCCC-0503, LCCC 0503, NCT00519831
10.	Vinflunine in Hormone Refractory Prostate Cancer (HRPC) Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: SCRI GU 35, NCT00545766
11.	A Study of the Alternative Administration of Ixabepilone and Vinflunine Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA183-008, NCT00362830
12.	Effect of Ketoconazole on the Pharmacokinetics of Vinflunine Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CA183-009, NCT00388557
13.	Phase I Study of Vinflunine in Combination With Either Erlotinib Hydrochloride or Pemetrexed Disodium in Patients With Unresectable or Metastatic Solid Tumors Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UNC-LCCC-0509, LCC 0506, NCT00320073